Publisher
Springer Science and Business Media LLC
Subject
Genetics (clinical),Drug Discovery,Molecular Medicine
Reference48 articles.
1. Chen Z, Xie H, Hu M, Huang T, Hu Y, Sang N, Zhao Y (2020) Recent progress in treatment of hepatocellular carcinoma. Am J Cancer Res 10:2993–3036
2. Gentile D, Donadon M, Lleo A, Aghemo A, Roncalli M, di Tommaso L, Torzilli G (2020) Surgical treatment of hepatocholangiocarcinoma: a systematic review. Liver Cancer 9:15–27. https://doi.org/10.1159/000503719
3. Garten A, Grohmann T, Kluckova K, Lavery GG, Kiess W, Penke M (2019) Sorafenib-induced apoptosis in hepatocellular carcinoma is reversed by SIRT1. Int J Mol Sci 20. https://doi.org/10.3390/ijms20164048.
4. Zhang Y, Xie C, Li A, Liu X, Xing Y, Shen J, Huo Z, Zhou S, Liu X, Xie Y et al (2019) PKI-587 enhances chemosensitivity of oxaliplatin in hepatocellular carcinoma through suppressing DNA damage repair pathway (NHEJ and HR) and PI3K/AKT/mTOR pathway. Am J Transl Res 11:5134–5149
5. Xu J, Ji L, Liang Y, Wan Z, Zheng W, Song X, Gorshkov K, Sun Q, Lin H, Zheng X et al (2020) CircRNA-SORE mediates sorafenib resistance in hepatocellular carcinoma by stabilizing YBX1. Signal Transduct Target Ther 5:298. https://doi.org/10.1038/s41392-020-00375-5
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献